Current FAC Members
Organizations on this page
- Anesthesiology
- Associate Research Scientist
- Cancer Center
- Cell Biology
- Cellular & Molecular Physiology
- Child Study Center
- Comparative Medicine
- Dermatology
- Emergency Medicine
- Genetics
- History of Medicine
- Immunobiology
- Internal Medicine
- Laboratory Medicine
- M.O.R.E
- Microbial Pathogenesis
- Molecular Biophysics and Biochemistry
- Neurology
- Neuroscience
- Neurosurgery
- Obstetrics, Gynecology & Reproductive Sciences
- Ophthalmology and Visual Science
- Orthopaedics and Rehabilitation
- Pathology
- Pediatrics
- Pharmacology
- Psychiatry
- Radiology & Biomedical Imaging
- S.W.I.M
- Surgery
- Therapeutic Radiology/Radiation Oncology
- Urology
- YSPH
Anesthesiology
Clinician
Mukadder Ozcan is an Assistant Professor of Anesthesiology at Yale University Department of Anesthesiology. She graduated from Dicle University Medical School in Diyarbakir, Turkey. Upon completing his anesthesiology residency at the Istanbul University Cerrahpasa School of Medicine, Dr. Mukadder Ozcan joined a cardiac anesthesia group at the American Hospital in Istanbul, where she worked for 5 years. Upon moving to USA, Dr. Ozcan joined the residency program at The University of Oklahoma Department of Anesthesiology, where she also continued as a faculty member upon completion. She was appointed as Assistant Professor at The University of Oklahoma after obtaining Board Certification by the American Board of Anesthesiologists in 2017. Dr. Mukadder Ozcan joined Yale Department of Anesthesiology in 2020 as Assistant Professor, where she continues to practice as a member of the Division of Adult Multispecialty Anesthesia. Her clinical focus is anesthesia for surgical oncology, where she provides perioperative care for gynecological, urologic, and general surgical patients. In addition to her clinical work, Dr. Ozcan remains committed to residency education and mentorship. Dr. Ozcan is also striving to be an advocate for her colleagues, being elected to represent her Department at the Faculty Advisory Council as well as serving as a member at the Faculty Engagement Committee within the Department of Anesthesiology.Clinical/Researcher
Dr. Patel is an Assistant Professor of Anesthesiology in the Division of Cardiac and Critical Care. He grew up in India and moved to the United States at the age of 18. He earned his bachelor's degree from Rutgers University. He then attended St. George’s University School of Medicine. He returned to Rutgers for Anesthesiology residency where he went onto serve as a chief resident. He then followed his passion for cardiovascular medicine to further sub-specialize in Adult Cardiothoracic Anesthesiology and Critical Care Medicine at the Texas Heart Institute/Baylor College of Medicine in Houston. Upon graduation, Dr. Patel joined the faculty of the Yale Section of Cardiac and Critical Care Anesthesiology. He splits his clinical time between Cardiac ORs and Cardiothoracic ICU. He specializes in management of patients with advanced heart failure needing mechanical circulatory devices such as LVADs and ECMO. He is a dedicated medical educator to our residents and fellows. He's evolving as a medical educator, completed Medical Education Fellowship in 2021 and is currently enrolled in Master's at Yale with focus on Medical Education.
Associate Research Scientist
- I am a neurobiologist specializing in Parkinson’s disease and neurodegeneration research, with a background in medical physiology. I am interested in studying the role of presynaptic endolysosomal system in neurodegeneration, particularly in Parkinson’s disease, with a long-term goal of unravelling how genetic and environmental perturbations disrupt presynaptic terminals and their aging, leading to neurodegeneration.My research background: My journey in neuroscience began during my Master's in Medical Physiology, where I developed a profound interest in the motor system and its disorders, prompting me to pursue a Parkinson's disease (PD) focused PhD. My work revealed mechanisms behind mice strain-dependent susceptibility to parkinsonian toxin MPTP, shedding light on ethnicity-based differences in PD prevalence. Additionally, we pioneered the delineation of age-related glial changes in the human nigra, which significantly contributed to the morphology-based identification of glial cell activation. Collaborations for PD drug development and exposure to patient deep brain stimulation surgeries further solidified my dedication to PD research, a commitment I carried into my postdoc at Yale. During my postdoc, I specialized in endolysosomal dysfunctions of PD, focusing on auxilin and GBA. I authored a highly cited review on this topic within a year of joining. In a recently published study, we unveiled how auxilin-linked PD involves dopamine transporter and synaptic vesicle sorting defects. While establishing the importance of auxilin and its function of presynaptic endocytosis in PD, this study also contributed a novel auxilin knockout mice model of PD which is now being used for drug testing. In another study, we delved into mechanisms of cognitive dysfunction in PD and dementia with Lewy bodies. We first showed that GBA-SNCA double mutant mice are a good model to study these conditions, and using snRNA-seq and proteomics, we uncovered α-synuclein pathology independent mechanisms for cognitive dysfunction of GBA-linked PD, along with a putative modifier. I was funded as PI/co-PI for both projects, which also brought collaborations resulting in four related research articles. I have also ardently pursued leadership and mentoring opportunities, gaining experience in independently steering projects, fostering collaborations, and mentoring students. Yale University recognized my undergrad mentorship with an award, while one of my undergrads won Yale Outstanding Student Employee award. I have raised and managed funds as PI, published as the corresponding author, reviewed federal grants, and contributed to several departmental initiatives like Chair search, establishing high-throughput microscopy at Imaging Core, etc. I've been committed to promoting inclusivity in science through diverse teaching programs, neuroscience outreach, diversity initiatives, and as a founding member of the Yale Neuroscience Postdoc Committee. I was chosen as an Associate for the Intersection Science Fellow Symposium (ISFS) 2023, which mentors and spotlights select postdocs across the US for the faculty job market.My future research: Dopaminergic presynaptic terminals are often the initial sites affected by neurodegeneration in PD. Nevertheless, their remarkable adaptability and dynamic nature within an otherwise post-mitotic soma present a substantial potential for novel PD therapeutics, if we gain an understanding of the factors underlying early presynaptic degeneration. Recent advances in PD genetics and cell biology have spotlighted the putative role played by the presynaptic endolysosomal system in early degeneration, particularly in processes such as presynaptic clathrin-mediated endocytosis and autophagy. My primary objective as a faculty member is to comprehend how dysfunction within the presynaptic endolysosomal system contributes to neurodegenerative mechanisms in PD. I plan to investigate novel PD-related mutations within presynaptic endolysosomal proteins, exploring their interactions with genetic and environmental risk factors, as well as the influence of age. These studies will reveal insights for innovative treatments and biomarker discovery in PD and related neurodegenerative conditions. With my extensive expertise in PD research and specialized training in endolysosomal dysfunctions, I'm well-prepared to take up this exciting and important work.RESEARCH SUPPORT/GRANTS:Michael J. Fox Foundation, Target Advancement Program Grant, Aug. 2021 – Sept. 2023Project: Pathogenic Mechanisms for Auxilin-mediated Parkinson's DiseaseRole: Co-Principal Investigator (US$150,000)U.S. Dept. of Defense, CDMRP Early Investigator Research Award, July 2019 - 21, NCE till 2022Project: Role of Lipid Dyshomeostasis in Cognitive Dysfunction of Parkinson's DiseaseRole: Principal Investigator (US$340,000) National Institute of Mental Health and Neurosciences (NIMHANS) Fellowship, May 2012 - April 2017Role: Ph.D. Scholar (INR 1,260,000, covers complete stipend for 5 years)Indian Council of Medical Research (ICMR), Declined as I received an extension for previous.Role: Senior Research Fellow (covers two-year PhD stipend)
Cancer Center
York St. Drs
Dr. Sabrina Browning received her medical degree from the University of Connecticut School of Medicine where she first confirmed her passion for caring for individuals with hematologic diseases. Her internship and residency were completed at Yale New Haven Hospital. After residency, Dr. Browning served as Amyloid Fellow at the internationally recognized Amyloidosis Center at Boston University School of Medicine and Boston Medical Center. In this position, she played a key role in the multidisciplinary care of and coordination for patients with immunoglobulin light chain (AL) amyloidosis and related diseases. She returned to Yale New Haven Hospital to complete her fellowship in Medical Oncology and Hematology. Upon joining as faculty in the Hematology section at Yale School of Medicine, Dr. Browning was the sole awardee of the Bernard Forget Scholarship for 2020-2021, which supports deserving individuals who are transitioning into an academic career in Hematology. Dr. Browning is a physician in the Smilow Multiple Myeloma and Gammopathies Programs and also sees patients in the Classical Hematology Clinic and she is incredibly passionate about the comprehensive management of patients with rare hematologic disorders including AL amyloidosis and hereditary hemorrhagic telangiectasia or HHT. Dr. Browning’s clinical and research interests include evaluating new treatments for multiple myeloma, AL amyloidosis, and other hematologic diseases and their impact on outcomes and quality of life for patients. With the support of the Frederick DeLuca Foundation and the DeLuca Center for Innovation in Hematology Research, she is also studying the association between metabolic syndrome, which can include obesity, high blood pressure, high cholesterol, and diabetes, and the development of monoclonal gammopathy and multiple myeloma with the aim to learn more about potential preventative strategies. Dr. Browning has a clinical and research interest in the management of issues such as bleeding and clotting in individuals with multiple myeloma and AL amyloidosis. Dr. Browning serves as the Principal Investigator on several clinical trials here at Yale for patients with multiple myeloma and AL amyloidosis and is interested in design of new clinical trials to further help her patients and others living with these diseases. Dr. Browning serves as the representative for the Yale Cancer Center on the Faculty Advisory Council for Yale School of Medicine. She is a member of the American Society of Hematology (ASH), the International Myeloma Society (IMS), and the International Society of Amyloidosis (ISA). As a member of the HHT center here at Yale she is also a registered physician with CureHHT. Dr. Browning is dedicated to providing patient-centered and compassionate care to individuals and their families through a team-based approach. She is also committed to teaching trainees at various levels of medical training.Care Center Drs
Maryam Lustberg, MD, MPH, is Director of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center, and Chief of Breast Medical Oncology at Yale Cancer Center. She is also an Associate Professor of Medicine (Medical Oncology). She has been recognized for her patient-focused care with awards that include being rated by Forbes as one of the top breast medical oncologists in the nation and named to the Castle Connolly list of “Regional Top Doctors,” and “Exceptional Women in Medicine” for 2020. She is currently participating in the American Society of Clinical Oncology (ASCO) Leadership Development Program. Learn more about Dr. Lustberg>> With an emphasis on improving the long-term outcomes for patients with breast cancer who have developed side effects associated with treatment, Dr. Lustberg will continue her research efforts at Yale. She is also focused on investigating novel blood-based biomarkers to identify recurrence and treatment toxicity earlier. She is an NCI-funded investigator and active in both ALLIANCE and SWOG Cancer Cooperative Groups. Dr. Lustberg collaborates widely with researchers from around the world, thriving in creating innovative multidisciplinary scientific teams. Her mentorship has been recognized by numerous awards including Best Teacher Award by Hematology Oncology Fellows and the Shining Star Award for Medical Student Mentorship. Nationally, Dr. Lustberg is a member of the ASCO Annual Meeting Education Committee, Patient and Survivor Care Education Committee, and Neuropathy Expert Guideline Panel. She is actively engaged in national patient advocacy organizations with a focus on improving shared decision making and increasing patient engagement in clinical trials. In addition, she serves as the President Elect and on the Board of Directors for the international organization Multinational Association of Supportive Care in Cancer (MASCC). She serves as an Associate Editor for the Journal of Cancer Survivorship. In the last decade, she has published over 140 peer-reviewed publications and book chapters. Dr. Lustberg received her medical degree from the University of Maryland where she also completed her residency and went on to complete a fellowship in medical oncology and in breast medical oncology at The Ohio State University before joining the faculty in 2010. She earned a Master's in Public Health from The Ohio State University in 2013.
Cell Biology
Cellular & Molecular Physiology
Child Study Center
Clinical
Dr. Paez, originally from the Dominican Republic, completed his medical education at the Universidad Iberoamericana (UNIBE) with honors. Throughout medical school, he actively volunteered at a local psychiatric hospital, passionately working to reduce mental health stigma in the Dominican community. After graduating, he received specialized training in Cognitive Behavioral Therapy (CBT), Motivational Interviewing, and Parent-Child Interaction Therapy (PCIT). Following his dedication as a psychotherapist in Philadelphia for four years, Dr. Paez pursued a residency in adult psychiatry at the renowned Icahn School of Medicine at Mount Sinai (Elmhurst) in New York City, where he distinguished himself as the chief resident. Fueled by his unwavering enthusiasm for child and adolescent mental health, he chose to continue his journey at the Yale Child Study Center, accepting a fellowship position. During his fellowship, his peers selected Dr. Paez as one of the Chief Fellows. Immersed in the rich academic and clinical environment, he fully embraced the opportunity to learn and contribute to cutting-edge research and compassionate care for young individuals. Furthermore, his commitment and expertise were evident as he joined the Yale Child Study Center faculty, assuming the role of Assistant Professor of Child Psychiatry and Associate Medical Director of the Child Inpatient Psychiatric Service. His tireless efforts and invaluable contributions led to his appointment to the esteemed Faculty Advisory Committee to the Dean, where he actively aims to help shape the future of the institution. Most recently, Dr. Paez is thrilled to have been appointed to serve as an Associate Program Director of the Child and Adolescent Psychiatry Fellowship Program, where he hopes to support and train future child and adolescent psychiatrists.Research
Dr. Carla Stover is a licensed clinical psychologist and Professor at the Yale University School of Medicine Child Study Center. Dr. Stover's research interests are focused on the impact of violence and trauma (particularly family violence) on child development and the advancement of best practice interventions for children and families affected by such violence exposure. Dr. Stover has provided clinical service to families impacted by domestic violence including acute/crisis response, as well as, longer term evidence based treatments like TF-CBT and Child Parent Psychotherapy. Dr. Stover has been awarded several grants from the National Institute on Drug Abuse to develop interventions for fathers with histories of intimate partner violence (IPV) and substance misuse. She developed Fathers for Change to enable fathers to reduce both their violence and substance use and improve their parenting. She has conducted trainings both nationally and internationally on engagement and treatment approaches for families impacted by trauma, IPV and substance misuse.
Comparative Medicine
- Dr. Xiaoyong Yang is a Professor of Comparative Medicine and of Cellular & Molecular Physiology at Yale University School of Medicine. He received B.S. from Nankai University, M.S. from Peking University, and Ph.D. from University of Alabama at Birmingham with Dr. Jeffrey Kudlow. He completed his postdoctoral training with Dr. Ronald Evans at The Salk Institute. Dr. Yang has published in Nature, Cell, Cell Metabolism, Molecular Cell, Genes & Development, PNAS, etc., and been frequently invited to speak at national and international conferences and academic institutions. Dr. Yang serves on scientific review panels for the NIDDK, NIGMS, NASA, American Diabetes Association, American Cancer Society, The Medical Research Council, The Wellcome Trust, Israel Science Foundation, and other agencies from around the world. Research in his laboratory is supported by The National Institutes of Health, The State of Connecticut, American Diabetes Association, American Heart Association, American Cancer Society and Ellison Medical Foundation.
Dermatology
- I am a physician-scientist who has trained in immunology, molecular biology, genetics and clinical dermatology. My overall career goal as a physician-scientist are to integrate fundamental immunology with clinical dermatology. In particular, I am interested in the role of costimulatory and inhibitory immune receptors in cancer immunity, autoimmunity pathogenesis and immunotherapy. My interest in this field was driven by my experience in the Medical Scientist Training Program at Washington University in St. Louis, where I worked in the laboratory of Dr. Robert Schreiber to decipher key molecular regulators of cancer immunoediting. As a consequence, the expertise gained in skin immunology and the emerging immunotherapies to treat melanoma inspired me to become a dermatologist. During my dermatology residency, I joined the laboratory of Dr. Lieping Chen at Yale School of Medicine, who pioneered targeting the PD-1 axis for cancer immunotherapy and has discovered multiple novel immune checkpoint molecules including programmed death receptor-1 homolog (PD-1H) (also known as VISTA). My current research interests include: 1) identification of novel immune checkpoints such as PD-1H/VISTA and others in cutaneous malignancies (e.g., melanoma and keratinocyte carcinomas) and 2) elucidating the inhibitory immune landscape of chronic inflammatory disorders such as psoriasis and cutaneous lupus erythematosus.
Emergency Medicine
- Cristiana Baloescu graduated from the Yale Emergency Medicine Residency Program in 2017. She completed medical school at Dartmouth Geisel School of Medicine in 2013. During residency, she conducted research in disaster preparedness, applications of machine learning in point-of-care ultrasound interpretation, and served as the resident director of medical student education. After graduating from residency, she pursued further training in point-of-care ultrasound fellowship, as well as a Masters degree in public health at Yale. Her goal is to advance the field of point-of-care ultrasound, establish programs in developing countries. She is from Bucharest, Romania, and attended Wesleyan College in Macon, GA. An avid international travel, she met her husband, also a physician-scientist, during an academic exchange program in Germany.
- Katja Goldflam, MD is an Associate Professor in the Department of Emergency Medicine. After graduating from the Warren Alpert Medical School of Brown University in 2006, Dr. Goldflam completed her residency at the Harvard Affiliated Emergency Medicine Residency in 2010. She completed a fellowship in Emergency Ultrasound at St. Luke's - Roosevelt Hospital Center in New York City and joined the Yale faculty in 2011. She is the Associate Residency Director for the emergency medicine residency and has an interest in education, competency assessment, feedback and leadership development. She has taught various ultrasound and wilderness medicine courses regionally and nationally and was awarded the 2017 ACEP National Emergency Medicine Faculty Teaching Award.
History of Medicine
- Marco Ramos, MD PhD, is Assistant Professor in the History of Medicine and Department of Psychiatry at Yale University. His research and teaching focus on the history of the mental health, with an emphasis on health activism and the history of drugs in Latin America. He is currently writing a book on Cold War violence and health justice in Argentina and is also starting a new project on the history of psychedelics, especially ayahuasca, in the Amazon. His writing has appeared in clinical, academic, and popular journals, including The American Historical Review, Bulletin of the History of Medicine, the New England Journal of Medicine, JAMA, and the Boston Review. His teaching brings a critical historical perspective to anti-racism interventions in science, medicine, and public health.
Immunobiology
- The Joshi laboratory uses intricate tumor models and advanced approaches to investigate immune cell interactions with developing tumors. The goal is to determine mechanistically why these interactions do not lead to more potent anti-tumor responses and to identify entry points for modulating these interactions through genetic manipulation and therapeutic intervention. Our studies focus on using established complex mouse models to investigate how subtypes of T cells function in the tumor microenvironment and how their interactions with other immune cell types impacts tumor development. Our laboratory combines advanced genetic modeling of mice and immunologic techniques to address fundamental questions in tumor immunology.
Internal Medicine
PhD's
I attended Cornell University and double majored in biochemistry and business management. After graduation I worked for a small start up company developing HIV therapeutics which solidified my love of research. I then attended Dartmouth Medical School where I worked on malaria and toxoplasma parasites and received my PhD in biochemistry. I was hooked on infectious and vector-borne diseases and came to Yale Medical School to complete a post-doctoral fellowship on Lyme disease and other tick-borne infections. I stayed on and became faculty in the Section of Rheumatology and have continued to investigate tick-borne diseases and the immune responses to them. I also pursued my love of teaching and teach both medical and undergraduate students.Pulmonary
Dr. Britto received his medical degree from the Luis Razetti School of Medicine at the Universidad Central de Venezuela in Caracas, Venezuela. He completed his Internal Medicine residency training at Albert Einstein Medical Center in Philadelphia.Dr. Britto completed his fellowship training in Pulmonary & Critical Care Medicine at Yale, followed by a Fellowship in Adult Cystic Fibrosis sponsored by the Cystic Fibrosis Foundation. During his fellowship, Dr. Britto became involved in research focused on the pathogenesis of airway diseases in the laboratory of his mentor, Lauren Cohn, M.D.Dr. Britto joined the faculty at Yale in 2013, where his clinical responsibilities include being a member of the Adult Cystic Fibrosis Program and attending in the Medical Intensive Care Unit. These activities complement his research program focused on understanding the role of the airway epithelium in the development of airway diseases such as asthma and cystic fibrosis.Patient Oriented Research
E. Jennifer Edelman, MD, MHS is a Professor of Medicine and Public Health. Certified as an internist, HIV specialist and in Addiction Medicine, she serves as an HIV provider and the physician consultant in the Addiction Medicine Treatment Program at the Yale-New Haven Hospital Nathan Smith HIV Clinic. Her research focuses on optimizing HIV prevention and treatment in the context of substance use, including opioid, alcohol and tobacco use. To this end and applying a range of methodologies, she leads and collaborates on NIH-funded projects to evaluate novel and implement evidence-based addiction treatment in medical settings, especially HIV treatment settings. In addition, her work has focused on understanding harms associated with opioid use among people with HIV. She collaborates with community-based and public health partners to promote HIV prevention, including use of pre-exposure prophylaxis (PrEP). She mentors trainees, including post-doctoral fellows and public health students, and is Associate Director of the Research on Addiction Medicine Scholars (RAMS) Program and co-Director of Education at the Yale Center for Clinical Investigation. She regularly serves on NIH grant review committees and is Associate Editor of Addiction Science and Clinical Practice.Basic Research
My major area of research interest include the endocytic process and matrix regulation in podocytes. Our laboratory has identified the critical role of the clathrin coated endocytic processes in the development and maintenance of podocytes. In-vivo animal models with conventional or conditional ablation of genes implicated for endocytosis, such as synaptojanin, endophilin, and dynamin develop severe proteinuria and foot process effacement. By utilizing fluorescently tagged proteins, we have visualized these proteins along with genes implicated to cause human nephrotic syndrome (CD2AP, Myo1e, Nephrin) lie at the interface of endocytosis and actin cytoskeleton. One of the major goals of the laboratory is investigating and further understanding the critical factors that are being endocytosed in podocytes. We have also sought to examine the role of cell matrix interactions by providing mechanistic insight on focal adhesion proteins and integrins, which govern podocyte cell adhesion and movement during health and disease states, using mouse genetic models of disease.Infectious Diseases, Geriatrics
How do we teach? As a clinician educator, my areas of interest and expertise involve curriculum development in geriatrics in both in hospital and out of hospital sites and disseminate geriatric learning through different teaching methods. In the past 7 years, I have developed a unique geriatric curriculum for Traditional Internal Medicine residents that encompasses geriatric learning at both in hospital and out of hospital sites as part of a block rotation. Being the Associate Fellowship Director, I created for our fellows a multidisciplinary curriculum at the Veterans administration working with Audiology, speech, low vision, physiatry, anesthesiology and chiropractic. In May of 2015 I accepted the role of co leader to one of the Master courses ( Across the Lifespan). We are part of the core working group on creating the new medical school curriculum that is now in its second year. Overall, my focus is on curricular reforms at different levels of trainee experience ( medical student, medical residents, inter professional trainees and geriatric medicine fellows)and to effectively evaluate the learning achieved through these curricular implementations.Investigators
Dr. Petersen is Professor of Internal Medicine, Section of Endocrinology, Yale University School of Medicine, Honorary Professor of Medicine and Clinical Physiology at University of Copenhagen, Deputy Director of the Metabolic Imaging and Liver Metabolism Section at the Center for Basic Metabolic Research, Copenhagen University, Denmark. Dr. Petersen received her bachelor’s degree from N. Zahle’s Gymnasieskole (majors: math & physics) in Copenhagen (1978) and her MD from the University of Copenhagen (1985), completed clinical training at the university hospitals, Copenhagen followed by the prestigious fellowships: Kandidat- and Seniorstipendiums for research in metabolism at the University of Copenhagen (1986-1991). In 1990 Dr. Petersen received further fellowship and postdoctoral training at Yale University in magnetic resonance (MR) spectroscopy and metabolism. At Yale University School of Medicine she became Research Scientist at in 1991, Assistant Professor in 1998, Associate Professor in 2004 and Professor in 2012. She has received prestigious awards for her clinical research, including: Henry Christian Award for Excellence in Clinical Research (1997, 1998, 2004) Novartis Young Investigator Award for Excellence in Clinical Research in Diabetes (2002) Glaxo Smith Kline Scholar Award (2003) Distinguished Clinical Scientist Award from the American Diabetes Association (2009) Team Science Award, Association for Clinical and Translational Science (2016) Dr. Petersen has published over 140 articles using stable isotopes MR spectroscopy to explore the pathogenesis of NAFLD, type 2 diabetes, insulin resistance in aging, obesity, and low birth weight and the reversal of NAFLD and insulin resistance with caloric restriction or exercise.General Med, A&I, Rheumatology, Infectious Diseases, Geriatrics, Endocrinology
Lisa Puglisi, MD is an Associate Professor of Medicine at Yale University where she practices primary care and addiction medicine. She is the director of Transitions Clinic-New Haven, a multi-disciplinary clinic that is part of a national network of programs that focus on care of individuals who are returning to the community from incarceration. Her clinical practice includes treatment of addiction and hepatitis C in primary care and she also oversees a medical legal partnership. She has developed specific skills in training, hiring and supervising community health workers and directing interdisciplinary teams of physicians, midlevel providers, community health workers, research personnel and legal colleagues around the work of clinical care and research to improve the health of people with recent incarceration. She is originally from the New Haven area and deeply committed to the community. Lisa received her undergraduate degree from Tufts University, her medical degree from Albert Einstein College of Medicine and completed her medical training at Yale New Haven Hospital.VA
Samit Shah is an Interventional Cardiologist who specializes in the invasive evaluation of coronary artery disease, coronary physiology, and complex coronary interventions. He was an undergraduate at the Pennsylvania State University and went to medical school at the University of Illinois College of Medicine, where he graduated with a medical doctorate as well as PhD in Neuroscience. He subsequently completed his internship and residency in Internal Medicine at Yale New Haven Hospital, followed by clinical fellowships in Cardiovascular Medicine, Peripheral Vascular Interventions, and Interventional Cardiology. Dr. Shah has received numerous honors for patient care and education, including the Dr. Lynda Rosenfeld Cardiology Fellowship Teacher of the Year Award, Wendy U. and Thomas C. Naratil Pioneer Award, Veterans Administration I CARE Award, and Yale Internal Medicine Excellence in Outpatient Care Award. In 2023, he was recognized by the Society of Cardiovascular Angiography and Interventions (SCAI) as a "30 in their 30's" award recipient for professional excellence in interventional cardiology. His scholarly work has focused on the outcomes of cardiovascular interventions and the invasive assessment of coronary physiology. He is the national co-principal investigator of the DISCOVER INOCA multi-center registry, and has active research projects at Yale regarding the diagnostic yield of invasive coronary physiology testing, ischemic heart disease in women, and the vascular effects of psychological stress.
Laboratory Medicine
- Dr. Joe El-Khoury is Director of the Clinical Chemistry Laboratory and the Clinical Chemistry Fellowship Program at Yale New Haven Health and Associate Professor of Laboratory Medicine at Yale University School of Medicine. Dr. El-Khoury is board certified by the American Board of Clinical Chemistry and a fellow of the AACC Academy. His research interests include indicators for monitoring clinical laboratory performance, investigating biomarkers of acute kidney injury and chronic kidney disease (in collaboration with the Clinical and Translational Research Accelerator) and development of new mass spectrometry-based methods for the measurement of markers in biological fluids.
M.O.R.E
- Dr. Johnson has certifications from the American Board of Surgery in General Surgery and in Surgical Critical Care. He also has certifications for Advanced Trauma Life Support Provider, Advanced Trauma Life Support Instructor, and Advanced Trauma Operative Management. Dr. Johnson earned his undergraduate degree from Morehouse College in Atlanta and his medical degree from Yale School of Medicine. He completed his residency training in general surgery from the University of Texas Medical Branch, Department of General Surgery in Galveston; and Vanderbilt University Medical Center, Department of General Surgery in Nashville. He was fellowship-trained in surgical critical care and acute care surgery at Yale School of Medicine, Department of Surgery. Dr. Johnson services as the Director of both the Surgical Intensive Care Unit and Surgical Services for the Saint Raphael's Campus.
Microbial Pathogenesis
- Dr. Ho's research program focuses on understanding HIV-1 persistence and HIV-1-induced immune dysfunction using single-genome and single-cell approaches on clinical samples. She received MD in 2002 (Phi Tau Phi) and completed internal medicine residency and infectious disease fellowship training in Taiwan in 2007. She practiced as an infectious disease attending physician for one year (2007-2008). She received PhD at Johns Hopkins University School of Medicine (Phi Beta Kappa, HHMI International Student Research Fellowship, and Johns Hopkins Young Investigator Award) in 2013, mentored by Dr. Robert F. Siliciano. During PhD, she developed the first HIV-1 full-length single-genome sequencing method that became the standard measurement of the size of the HIV-1 latent reservoir (Cell 2013). As a postdoc, she profiled HIV-1 DNA and RNA landscape and identified the impact of cytotoxic T lymphocytes (CTLs) and defective HIV-1 proviruses on HIV-1 persistence (Cell Host Microbe 2017, Best Paper of the Year, corresponding author). After she started my lab at Yale University in September 2017, she developed single-cell HIV-1 SortSeq and identified HIV-1-driven aberrant cancer gene expression at the integration site as a mechanism of HIV-1 persistence (Science Translational Medicine 2020).She developed CRISPR-ready HIV-1-infected cell-line models and a dual-reporter drug screen to identify drugs that can suppress HIV-1-induced cancer gene expression (JCI 2020). She is currently working on understanding HIV-1-induced immune dysfunction and clonal expansion dynamics of HIV-1-infected cells using single-cell multi-omic ECCITEseq on clinical samples (Immunity 2022). She found that HIV-1 preferentially persist in cytotoxic CD4+ T cells. She also found that antigen stimulation and tumor necrosis factor (TNF) as key drivers for the clonal expansion of HIV-1-infected cells. This is the first time identifying single-cell transcriptional landscape of HIV-1 RNA+ cells at their in vivo state without ex vivo stimulations. In addition, she used a genomewide CRISPR screen and identified HIV-1 silencing factors including SAFB family proteins and RNA nuclear exosome complex (J Virol 2022). Dr. Ho's research support mainly comes from NIH, with an R21 funded 1 year after PhD graduation and two R01-level grants funded within one year after she started her lab at Yale University. She is focusing on using single-cell genomic approaches to understand HIV-1 persistence. She is an Investigator for basic science and translational collaboration projects, such as NIH Structural Biology Center CHEETAH, NIH Martin Delaney Collaboratory BEAT HIV and REACH, a UM1, and a P01.
Molecular Biophysics and Biochemistry
- Wendy Gilbert is a Professor of Molecular Biophysics and Biochemistry. Her work focuses on regulatory elements in messenger RNA that control the cellular expression of the information stored in the genetic code. She earned her PhD at UCSF with Christine Guthrie, studying mRNA export and being fascinated by the exquisite mechanisms that couple export-competence to completion of RNA processing. As a postdoc in Jennifer Doudna’s lab at UC Berkeley, she uncovered a non-canonical mechanism of translation initiation. Her lab’s current work ranges widely across RNA biology with the unifying theme of elucidating the molecular mechanisms of RNA regulatory elements controlling mRNA biogenesis, translation and decay. Most recently, this has been in the area of RNA base modification. Notable awards include the RNA Society’s Early Career Award (2017) for her “paradigm-altering contributions to the field of post-transcriptional gene regulation” and the RNA Society Award for Excellence in Inclusive Leadership (2023) for her efforts to promote the training and professional development of underrepresented scientists.
Neurology
Clinical
I am a Neurologist with subspecialty training in Neurocritical Care and Stroke, and an Epidemiologist with expertise in Population Genetics and Big Data. While on clinical duties, I treat critically ill patients that have sustained a significant neurological injury due to ischemic stroke, subarachnoid hemorrhage, intraparenchymal hemorrhage, traumatic brain injury, seizures, recent neurosurgery, decompensated neuromuscular diseases, and several others. My research lies at the interphase of clinical neurology, neuroimaging, population genetics and genomic medicine. I am interested in understanding how common and rare genetic variation influences the occurrence, severity, functional outcome and recurrence of stroke, both hemorrhagic and ischemic. Genetic variants influencing these phenotypes can be used for numerous applications, including: (1) identification of novel biological mechanisms involved in causing stroke and determining its severity and outcome, (2) answering non-genetic epidemiological questions using gene mutations as instruments (in the statistical sense of the word), and (3) risk stratification of patients according to their genetic profile. Through the International Stroke Genetics Consortium, I work in close collaboration with numerous investigators interested in stroke genomics from around the world.- Dr Bhaskar Roy is a specialist in neuromuscular disorders. His clinical areas of expertise includes muscular dystrophies, inflammatory myopathies (polymyositis, dermatomyositis, inclusion body myositis), autoimmune neuromuscular disorders, including inflammatory neuropathies. He did his neurology residency from the University of Connecticut and completed his fellowship from the Beth Israel Deaconess Medical Center, Harvard Medical School. He is board certified in neurology (2016) and neuromuscular medicine (2018) by the American Board of Psychiatry and Neurology (ABPN) and in electrodiagnostic medicine (2018), and in Neuromuscular Ultrasound (2020) by the American Board of Electrodiagnostic Medicine (ABEM).
Neuroscience
- Liang Liang received her B.S. in Mathematics and Physics from Tsinghua University in China. She then moved to the United States and completed her M.S. and Ph.D. in Applied Physics at Stanford University under the supervision of Drs. Liqun Luo and Mark Schnitzer. During her graduate work, Liang identified a novel circuit motif that recruited excitatory and inhibitory channels in parallel to shape odor processing in the fruit fly, using two-photon imaging, laser dissection and optogenetics. She was supported by a Stanford Graduate Fellowship and a Lubert Stryer Stanford Interdisciplinary Graduate Fellowship. Liang joined the groups of Drs. Chinfei Chen and Mark Andermann at Harvard Medical School for her postdoctoral training, where she studied functional organization and state-dependent modulation of retinal axons in the early visual system of awake behaving mice. She was supported by a postdoctoral fellowship from the Simons Collaboration on the Global Brain (SCGB). Liang joined the Department of Neuroscience at Yale School of Medicine as an Assistant Professor in 2020. Her laboratory studies the computation of information selectivity along the visual hierarchy with a primary focus on the visual thalamic circuitry, taking a combination of in vivo imaging, genetic, behavioral, and computational approaches.
Neurosurgery
- Dr. Sacit Bulent Omay works as an Associate Professor of Neurosurgery and Otolaryngology . He co-directs Yale Pituitary and the Yale Neurotrauma programs. He also conducts skull base, pituitary, and brain tumor surgery with expertise in endoscopic and minimally invasive treatments. He completed his neurosurgery residency at Yale Medical School. His fellowships include a surgical neuro-oncology fellowship in Cleveland Clinic and a Minimally Invasive Endoscopic Skull Base and Pituitary Fellowship at Weil Cornell Medical Center. His clinical interests include skull base and pituitary pathology, brain tumors and traumatic brain injury. He is certified by The American Board of Neurological Surgery.
Obstetrics, Gynecology & Reproductive Sciences
Obstetrics
Most of the time, having a baby goes according to plan. For those rare times when issues arise, Yale’s Dr. Katherine Kohari is there to step in. Dr. Kohari specializes in high-risk pregnancies with complications that threaten the well-being of mother, baby, or both. “I enjoy helping mothers navigate through the exciting, yet complex, parts of pregnancy and childbirth,” she says.Kohari joined the Obstetrics, Gynecology and Reproductive Medicine Department’s Division of Maternal-Fetal Medicine in 2014. In 2007, she received her MD from New York Medical College in Valhalla, New York, where she was inducted into the Alpha Omega Alpha Medical Honor Society. Dr. Kohari furthered her training with an Ob/Gyn residency and a Maternal-Fetal Medicine fellowship at the Icahn School of Medicine at Mount Sinai in New York City.As part of the Maternal-Fetal Medicine group, Kohari sees patients both in New Haven and at satellite offices in Westport and Norwalk, Connecticut. These offices were opened to enable women in the Fairfield County area to see Yale physicians much closer to home. Dr. Kohari’s practice employs the latest 2D and 3D ultrasound technology to maximize early and accurate diagnoses. She also performs diagnostic procedures such as CVS and amniocentesis. “If we diagnose an abnormality in utero, we can discuss a care plan prior to delivery; the obstetrician, pediatrician and pediatric subspecialist work together to organize timing of delivery, mode of delivery and where the physical delivery should happen,” she explains.Dr. Kohari is a member of the American Congress of Obstetricians and Gynecologists, the Society for Maternal-Fetal Medicine and the New Haven Obstetrical Society.
Ophthalmology and Visual Science
- Dr. Volker specializes in comprehensive eye exams, spectacle corrections, and contact lenses. She fits specialty contact lenses for astigmatism, presbyopia (bifocal lenses), keratoconus, post-refractive surgery patients, post-corneal graft patients, and pediatric and adult aphakic patients. She earned her BA in Molecular and Cell Biology at UC Berkeley, where she also earned her Doctor of Optometry (O.D.). She completed her residency in ocular disease at Bascom Palmer Eye Institute in Miami FL. She is currently pursuing her fellowship with the American Academy of Optometry.
Orthopaedics and Rehabilitation
- Dr. Matthew D. Riedel joined Yale Orthopaedics and Rehabilitation as an Assistant Professor of Orthopaedic Surgery. Riedel, an Orthopaedic Trauma Surgeon and graduate of Vagelos College of Physicians and Surgeons at Columbia University, says his passion for trying to unravel mechanical problems started at his father’s tool and die shop. He appreciated the puzzles his father faced in making the proper tools for the job, and the problem-solving associated with it. He wasn’t inherently focused on medicine from a young age, but was attracted to the field that allowed him to take an engineer’s approach to making patients whole. Orthopaedic traumatologists are required to be jacks-of-all-trades, Riedel says. “Everything that goes on here at Yale is centered around improving care and life for the patients. You have every different subspecialty available where physicians are able to work together as a team to solve complex problems using the latest research and technologies. That’s very appealing to me,” Riedel says. Riedel joins the department after completing a post-doctoral fellowship in orthopaedic traumatology at the R. Adams Cowley Shock Trauma Center at the University of Maryland Medical Center in Baltimore. He completed his residency in orthopaedic surgery at Harvard Medical School’s Combined Orthopaedic Residency Program in June 2018, and was previously a Doris Duke Pre-Doctoral Clinical Research Fellow at Columbia University Medical Center. “I love that my week is a mix of different things. I’m operating or in clinic most days each week. I’m doing research. I’m teaching. I’m doing all of these different things so that every day is different than the last, but it also allows me to keep things fresh,” Riedel says. “Every day I have an opportunity to help people, whether that’s by teaching, surgery, or improving people’s lives.” He takes his approach to the laboratory too, where his research has been published in Injury and The Journal of American Academy of Orthopaedic Surgeons. Riedel says that working at Yale allows him to not only continue performing surgeries, but also to be at the forefront of the latest research. “I’ve always enjoyed putting things together and the challenge of facing complex problems,” Riedel says. “Every case is different as a trauma surgeon. Everything you do, you think about in different ways. It challenges you every day because you don’t know what the next day may bring. I think that’s really fun and interesting to me.”
Pathology
Research
Dr. Dhanpat Jain is a Professor of Pathology and Internal Medicine (section of Digestive Diseases). Dr. Jain graduated from Mysore Medical College, Mysore, India and received his M.B.B.S degree in 1986. He subsequently received his M.D. Pathology degree from Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India in 1991. He moved to the U.S. in 1995 and completed his Anatomic Pathology residency and Fellowship in Gastrointestinal Pathology at Yale University School of Medicine, and subsequently continued as a faculty there.Dr. Jain is a nationally and internationally recognized gastrointestinal pathologist known for his diagnostic skills, research and teaching. He has more than 150 publications, many book chapters, books and reviews, all of which are largely in the field of gastrointestinal and liver pathology. He has delivered many lectures and participated in many courses at the national and international level. He is on the editorial board of several high impact journals in the field of gastrointestinal and liver disorders. His area of expertise is motility disorders of the gastrointestinal tract, for which he gets cases in consultation from across the globe. Dr. Jain is an accomplished teacher and has received many awards. He has continuously been nominated for “Best Doctors in America” for many years.
Pediatrics
Adolescent Medicine; Allergy & Immunology; General Pediatrics; Endocrinology; Nephrology
After receiving undergraduate and medical school degrees from the University of Michigan and undergoing a categorical pediatric residency at Weill-Cornell/NY Medical Center, Dr. Fenick was in private practice for 6 years. Her practical experience is augmented by national and local work in education and educational scholarship. Dr. Fenick has been the co-editor of the Yale Primary Care Pediatrics Curriculum since its inception, and is now the associate director for Pediatrics in the primary care component of the Biopsychosocial Approach to Health, a third-year medical student core clerkship. She is also honored to serve as Medical Director for YNHH's School Based Health Centers, and as Medical Director for the Medical-Legal Partnership Project at YNHCH. Her research and advocacy centers on pediatric primary care in the service of growing children to be healthy, happy, and productive adults.#ChildrenFirstCritical Care; Hospitalist; Neonatal- Perinatal Medicine; emergency Medicine
Dr. Angela Montgomery is an Associate Professor of Pediatrics and the Director of the NICU GRAD follow-up program at Yale-New Haven Children's Hospital. Having completed a master's degree in special education prior to medical training, Dr. Montgomery has a specific clinical and research interest in the long-term neurodevelopmental and neurobehavioral outcomes of at-risk infant populations. Her research interests focus primarily on the impact of the NICU environment and various neonatal practices on at-risk infant outcomes and the early identification of autism in very low birth weight (VLBW) populations. Dr. Montgomery received her master's degree in special education from Hunter College/CUNY and her medical degree from New York Medical College. She completed her Pediatric Residency and Neonatology Fellowship at Yale University.Cardiology; GI, Hematology/ Oncology; Infectious Disease; Neurology; Respiratory
Dr. Pashankar completed his basic medical training in India and in the UK. He completed fellowship training in Pediatric Gastroenterology at BC Children's Hospital in Vancouver, Canada. He has MBA in healthcare from Yale School of Management and has expertise in process and quality improvement. His clinical and research interest is in inflammatory bowel disease in children. He is the director of Yale Pediatric Inflammatory Bowel Disease Program. He runs a multidisciplinary Inflammatory Bowel disease clinic at Yale New Haven Children's Hospital in New Haven. He has published a number of clinical studies in quality improvement, pediatric gastroenterology and inflammatory bowel diseases. He is a regional medical director of Yale Medicine ambulatory services and oversees Yale Medicine clinics in Fairfield county, New Haven and shoreline regions.
Pharmacology
Psychiatry
CMHC
I am a native of Augusta, Georgia, and an honored second-generation graduate of the Medical College of Georgia (MCG). Ever the Francophile, I completed my undergraduate education in psychology and French studies at Concordia University in Montreal, Quebec, Canada. I am trained in psychiatry by both the University of Pennsylvania and by my alma mater, MCG. I joined the Yale School of Medicine as Assistant Professor of Psychiatry in September 2019. My primary clinical appointment is at the Connecticut Mental Health Center. There, I am able to marry my dedication to provide quality clinical care to racially minoritized populations with academic research. My professional identity is rooted in being a fiercely proud, outspoken, family-oriented ethnic Black American physician descended of enslaved persons. I am a strong supporter of sociohistorical racial representation in medicine. My research interests focus on promoting historically-informed racial justice within academic medicine and addressing iatrogenic influences of poor patient care, specifically racism and mental health discrimination within daily clinical practice. My work in iatrogenesis has led me to become a national advocate for patient and provider safety through promoting the equitable treatment of behavioral emergencies by removing police- and security-based interventions from general hospital medicine.YNHH
Ebony Dix is an Assistant Professor of Psychiatry and Medical Director of the Geriatric Psychiatry Inpatient Unit, located at YNHH-Saint Raphael Campus (SRC). She leads a multidisciplinary team and provides clinical care for patients She is also an attending psychiatrist for the Yale Interventional Psychiatric Service, providing ECT consultations and treatments at SRC. In addition to leading a multidisciplinary team and providing clinical care for patients, her dedication to teaching and education is demonstrated by the transformation of the unit into a robust clinical teaching service for medical students, PA students, psychiatry residents, and geriatric psychiatry fellows.Clinical Research
Dr. Fesharaki is currently a neuropsychiatrist, as well as a basic neuroscience researcher focusing on Traumatic Brain Injury and Chronic Traumatic Encephalopathy. He has a diverse training background, which include a mixture of clinical adult psychiatry, clinical behavioral neurology/neuropsychiatry and bench neuroscience skills. This combination of aforementioned skills has in turn given him a unique vantage point to have the opportunity to apply what he continues to learn in the laboratory to enrich his clinical treatment. His current research focus is to develop a robust animal model of Chronic Traumatic Encephalopathy (CTE), as well as investigation of potential treatment modalities. He is also involved in a collaborative research study investigating synaptic density alterations in behavioral variant frontotemporal dementia (bvFTD).Clinical Research
I am an expert in tobacco and hazardous alcohol use, other modifiable lifestyle risk behaviors (i.e., deficient sleep, and physical inactivity), and digital health technology. My research focuses on: 1) better understanding and predicting these risks; 2) phenotyping risk variability within individuals; 3) developing novel lifestyle interventions that are tailored to these unique risk profiles; and 4) implementing lifestyle risk behavior/mental health screening and intervention in clinical settings. I utilize various technologies including biosensors, smartphones, telehealth, and electronic health record tools to monitor these behaviors, derive integrated biometric feedback, deliver interventions, and improve healthcare. In addition, I am interested in digitally-derived endpoints as alternative endpoints for clinical trials. In a separate and distinct line of research, I study the effects of different tobacco products and their constituents in adults to inform the regulation of tobacco products by the FDA. I also direct the Tobacco Treatment Service at Smilow Cancer Hospital and teach/mentor graduate students, residents, fellows, and junior faculty in addiction, behavioral medicine, health technology, and clinical research. Current studies include: (1) Observational Study: phenotyping heavy drinking and alcohol use disorder risk in young adults using advances in web-based neuropsychological assessment, smartphone sensing technology, machine learning and statistical modeling (n=350) (2) RCT: evaluating effects of e-cigarettes vs. oral nicotine pouches and their constituents (menthol flavor, nicotine concentration) on cigarette smoking in adults (N=256) (3) RCT: testing a personalized sleep/cardiovascular wellness feedback intervention using the OuraRing and smartphone diaries for young adults who drink heavily (n=60)Basic Research
Dr. Matt Girgenti is an Assistant Professor of Psychiatry at Yale School of Medicine. He is a neuroscientist and molecular biologist and a member of the Division of Molecular Psychiatry and the Wu Tsai Institute at Yale. He is also a VA-NCPTSD Research Scientist at the West Haven VA Medical Center. He received his doctoral degree at the University of Connecticut in molecular neuroscience. He completed his postdoctoral fellowship in Molecular Psychiatry at Yale followed by a VA Career Development fellowship in postmortem brain genomics. His early research focused on the epigenetic basis of schizophrenia using neural stem cells to demonstrate a role for the SCZ-risk gene ZNF804a as a gene transcription regulator. During his postdoc, his research focused on the cell-type-specific effects of rapid antidepressants, including ketamine and scopolamine using pharmacogenomic approaches. During his VA Career Development fellowship he worked on human postmortem studies focused on the functional genomics of neuropsychiatric disorders, specifically PTSD and major depression. He published the first genome-wide transcriptomic study of the human PTSD brain (Girgenti MJ, et al. 2021). His research now focuses on genomic studies of the postmortem human brain, combining molecular biology and bioinformatics to understand the neurobiology of major brain and behavioral disorders, including depression, PTSD, and alcohol use disorder.
Radiology & Biomedical Imaging
Bioimaging Sciences
Chi Liu received his Ph.D. in 2008 from Johns Hopkins University with emphasis on quantitative SPECT/CT imaging. Following his graduate work, he was a postdoctoral fellow at University of Washington, specializing in oncological PET/CT studies with emphasis on compensation algorithms for respiratory motion. In 2010, he joined Yale University as a faculty member. He is board certified in Nuclear Medicine physics and instrumentation by the American Board of Science in Nuclear Medicine. His current research focuses on quantitative cardiac and oncological PET/CT and SPECT/CT imaging, including deep learning algorithms, reconstruction algorithms, data correction, dynamic imaging, and translational imaging. The translational and clinical applications of these projects include early detection of chemotherapy-induced cardiotoxicity, multimodality imaging of heart failure, and eliminating respiratory motion variability for assessing response to therapy. Many of the imaging technologies developed in his lab has been or is being implemented in clinical PET and SPECT scanners. In 2012, he was awarded with the Bruce Hasegawa Young Investigator Medical Imaging Science Award from the IEEE Nuclear Medical and Imaging Sciences Council for “contributions to the imaging physics of SPECT/CT and PET/CT, with emphasis in quantitative imaging and motion correction”. He was the President of Physics, Instrumentation, and Data Sciences Council (PIDSC) of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) between 2022-2023, is currently the Immediate Past President of PIDSC.Interventional Radiology
Dr. Schlachter is an Assistant Professor of Radiology and Biomedical Imaging at the Yale School of Medicine.Dr. Schlachter's research interests include: Liver Cancer and diseases involving the liver.Dr. Schlachter completed his surgical intern year at the University of Pennsylvania School of Medicine and his Radiology Residency from the University of Connecticut School of Medicine. After finishing his Interventional Radiology fellowship at Johns Hopkins School of Medicine in 2012, he was hired as an Attending where he focused on treating a wide range of vascular diseases including liver cancer. Dr. Schlachter is committed to working together to determine the most effective treatments for his patients.
Surgery
Research
Dr. Arhuidese is a vascular and endovascular surgeon who is certified by the American Board of Surgery. He is highly specialized in the use of medical, endovascular and open surgical therapies for the treatment of vascular diseases. He holds concurrent appointments in the Department of Surgery in the Yale School of Medicine, Department of Chronic Disease Epidemiology in Yale School of Public Health, and in the Section of Biomedical Informatics and Data Science in the Yale School of Medicine. His clinical interests include aortic aneurysms and dissections, peripheral arterial disease, carotid disease, creation and maintenance of durable access for hemodialysis, renal and mesenteric ischemia, thoracic outlet syndrome as well as the spectrum of venous diseases. He promotes communication strategies that facilitate shared decision making by patients, their families and the health team. Dr. Arhuidese pays meticulous attention to detail to ensure that patients have a safe and positive experience in the pre-, intra- and post- operative/procedural periods. He applies current research evidence in determining: if and when patients require surgery/procedures; and the surgery/procedure that best fits each patient based on their unique characteristics. He promotes disease prevention strategies that help patients avoid surgical procedures if possible. Dr. Arhuidese obtained his medical degree from the University of Benin in Nigeria. He served as Speaker of Congress and subsequently President of the Medical Students Association. He completed a Master’s in Public Health with a focus in Epidemiology & Biostatistics at the Johns Hopkins School of Public Health. He also underwent a Research Fellowship in Vascular & Endovascular Surgery at Johns Hopkins School of Medicine. He was recipient of the Johns Hopkins Bloomberg School of Public Health Capstone Research Award. He completed Vascular & Endovascular Surgery Residency at the University of South Florida where he was inducted into the Alpha Omega Alpha Medical Honor Society and awarded the Larey C. Carey Best Resident Research Award twice! His research is focused on understanding how pre- and peri-operative patient, provider and system based factors affect short and long term outcomes after vascular interventions. His research has been presented at numerous local, regional and national meetings; and published in national and international journals. He collaborates with experts across disciplines in medicine, public health, engineering, computer science and others to identify and promote novel solutions to vascular problems at individual and population levels.Associate with General Surgery
Dr. Gibson (nee Quinn) is an Endocrine Surgeon and Associate Professor of Surgery at Yale School of Medicine. Her clinical interests are surgery of the thyroid, parathyroid and adrenal gland, including minimally-invasive laparoscopic and retroperitoneoscopic surgical techniques. In addition, she serves as the Associate Clerkship Director for the Yale School of Medicine General Surgery Clerkship and is the Fellowship Director of the Endocrine Surgery Fellowship Program. Her research interests include outcomes after minimally-invasive endocrine surgery (thyroid, parathyroid, adrenal), outpatient thyroidectomy and parathyroidectomy, intraoperative laryngeal nerve monitoring, and endocrine oncology. She obtained her MD from Virginia Commonwealth University School of Medicine, Richmond, VA. She was a postdoctoral research fellow in In Utero Stem Cell Transplantation at The Children's Hospital of Philadelphia (CHOP), Philadelphia, PA. She completed her training in General Surgery at Saint Barnabas Medical Center, Livingston, NJ, and Endocrine Surgery at Scott and White Memorial Hospital, Temple, TX. Watch a video with Dr. Courtney Gibson >>Associate with Subspecialties
Douglas M. Hildrew, MD is an Assistant Professor at the Yale School of Medicine in the Section of Otolaryngology—Head and Neck Surgery who specializes in Otology, Neurotology, and Skull Base Surgery. He treats both adult and pediatric patients, and his clinical/surgical interests include cochlear implantation, middle ear implants, chronic ear disease, cholesteatoma, facial nerve disorders, facial nerve reanimation, otosclerosis (stapes surgery), superior semicircular canal dehiscence, glomus tumors, cerebellopontine angle tumors (e.g. acoustic neuromas), cerebrospinal fluid leaks (CSF leaks), and skull base surgery. Watch a video with Dr. Douglas Hildrew >>Dr. Hildrew earned his medical degree from the State University of New York in Syracuse, NY, and completed his residency in Otolaryngology — Head and Neck Surgery at the Tulane University School of Medicine in New Orleans, LA. In addition, he completed advanced fellowship training in Otology, Neurotology, and Skull Base Surgery at the University of Pittsburgh Medical Center (UPMC). Dr. Hildrew is a member of the American Academy of Otolaryngology — Head and Neck Surgery, American Neurotology Society, North American Skull Base Society, American College of Surgeons, the Triological Society, and the American College of Surgeons. Dr. Hildrew is Board Certified in Otology, Neurotology and Skull Base Surgery by the American Academy of Otolaryngology — Head and Neck Surgery and serves on multiple national committees.
Therapeutic Radiology/Radiation Oncology
- Dr. Christopher J. Tien is an Associate Professor and Lead Brachytherapy Physicist in the department of Therapeutic Radiology. In addition to his appointments at Yale, Dr. Tien is an Adjunct Associate Professor at Brown University. Dr. Tien practiced at a community hospital in suburban Chicago for 3 years after completing his residency at Brown University/ Rhode Island Hospital. He completed his PhD by the time he was 25 years old from the University of Florida, which he attended on a full fellowship. Clinically, he is a board-certified therapeutic medical physicist appointed as a Medical Physicist at Yale-New Haven Hospital. His current translational research is largely inspired by his clinical duties in brachytherapy (gynecological, prostate, ocular, and skin) applications and radiobiological modeling. Dr. Tien is a full member of the American Brachytherapy Society (ABS), the American Association of Physicists in Medicine (AAPM), the American Society for Radiation Oncology, and the Yale Cancer Center. He is currently the chair of the national AAPM Task Group on high-dose-rate brachytherapy (TG59). He has served terms on the national AAPM Board of Directors and as the Connecticut AAPM president. He is a member of the national AAPM Medical Physics Education Subcommittee and ABS National Education Subcommittee.
Urology
- Dr. Angela Arlen completed her pediatric urology fellowship at Emory University/Children’s Healthcare of Atlanta in 2014, and joined the Department of Urology as an Assistant Professor in 2017. Dr. Arlen specializes in all aspects of pediatric urology, with a special interest in minimally invasive surgery, as well as reconstructive urology including hypospadias repair and management of children with myelomeningocele. She participates in the multidisciplinary spina bifida clinic, providing specialty care to children with neurogenic bladder. Dr. Arlen’s research interests include hypospadias and vesicoureteral reflux clinical outcomes.
YSPH
- Professor Jody Sindelar is a professor of public health, health economist, and public policy expert in the Department of Health Policy and Management at Yale School of Public Health (YSPH), as well as with Yale’s Department of Economics. In addition, she is a research associate at the National Bureau of Economic Research (NBER), research fellow at the IZA Institute of Labor Economics, and faculty fellow at Yale’s Institution for Social and Policy Studies (ISPS). She is also a founding member and past president of the American Society of Health Economists (ASHEcon).Professor Sindelar’s expertise is on the economics of substance abuse, including addictive substances of tobacco/vaping, alcohol, and illicit drugs. She has published on the impacts of substance abuse on productivity, educational attainment, gender differences, and other policy issues; and in various journals of economics, policy, addiction, health and medicine. Also, she has served on numerous editorial, review, and advisory boards and committees, and has presented her research at seminars and conferences both nationally and abroad. Professor Sindelar has given keynote addresses to conferences in the United States, Australia, Germany, Italy, and Sweden. She has also been a visiting professor at several universities and institutes, including Boston University in Boston, MA; the Rand Corporation in Santa Monica, CA and Washington, DC; Centro de Investigación y Docencia Económicas (CIDE) in Mexico City, Mexico; and Shanghai Jiao Tong University Medical School in Shanghai, China. In addition, she has had sabbaticals at the Institut d'études Politiques de Paris (Paris Institute of Political Studies) in Paris, France; Stanford University in Stanford, CA; and the University of Pennsylvania.Professor Sindelar has been a principal investigator or collaborator on numerous research projects funded by various organizations, including the Agency for Healthcare Research and Quality (AHRQ); Centers for Medicare and Medicaid Services (CMS); Connecticut Department of Social Services (DSS); Food and Drug Administration (FDA); National Institute of Alcohol Abuse and Alcoholism (NIAAA); National Institute of Mental Health (NIMH); National Institute on Aging (NIA); National Institute on Drug Abuse (NIDA); Robert Wood Johnson Foundation (RWJF); Department of Veterans Affairs (VA); Yale Center for Clinical Investigation (YCCI); and the Federal Drug Administration.